Standard BioTools Net Worth 2010-2024 | LAB
Interactive chart of historical net worth (market cap) for Standard BioTools (LAB) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Standard BioTools net worth as of November 22, 2024 is $0.6B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.603B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.263B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.580B | 174.01 |
| Hims & Hers Health (HIMS) | United States | $5.276B | 134.17 |
| Enovis (ENOV) | United States | $2.580B | 17.49 |
| Privia Health (PRVA) | United States | $2.530B | 210.80 |
| IRhythm Technologies (IRTC) | United States | $2.313B | 0.00 |
| Azenta (AZTA) | United States | $2.227B | 111.05 |
| Omnicell (OMCL) | United States | $2.043B | 66.83 |
| Clover Health Investments (CLOV) | United States | $1.684B | 0.00 |
| 10x Genomics (TXG) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.484B | 0.00 |
| Phreesia (PHR) | United States | $1.098B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Talkspace (TALK) | United States | $0.559B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.518B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.491B | 85.00 |
| Health Catalyst (HCAT) | United States | $0.466B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| TruBridge (TBRG) | United States | $0.239B | 69.61 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
| HeartBeam (BEAT) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.038B | 0.00 |
| Movano (MOVE) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.010B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |